Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-08-18

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluvoxamine maleate (generic fluvoxamine) from Endo USA, Inc., updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)